<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03059043</url>
  </required_header>
  <id_info>
    <org_study_id>20170121</org_study_id>
    <nct_id>NCT03059043</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation</brief_title>
  <official_title>Prospective, Multicenter,Randomized Clinical Investigation of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation to Treat High Myopia: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wenzhou Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the safety and efficacy of a viscoelastic-free method for Implantable
      Collamer Lens(ICL) implantation to treat high myopia. Subjects were randomly assigned either
      to the new method group or to the control group which uses the standard method for
      implantation. The post-operative data are collected for analysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Implantable Collamer Lens(ICL) implantation has been proved to be an effective refractive
      option for surgical correction of high myopia. Currently, standard method utilizing the
      viscoelastic agent to fill and maintain the anterior chamber during the implantation, this
      requires an additional step to remove the viscoelastic agent at the end of the surgery and
      may cause the intraocular pressure spike in the early post-operative phase due to the
      incomplete removal of the viscoelastics. The new method is viscoelastic-free, which can be
      achieved by using balanced salt solution irrigation during the implantation.

      This study is a prospective randomized controlled trial to compare the safety and efficacy of
      the viscoelastic-free method with the standard method. Subjects enrolled in the study will be
      randomized to receive either viscoelastic-free method or standard method, and the clinical
      outcomes of two groups will be assessed at several follow-ups: 2 hours, 1 day, 1 week, 1
      month, 3 months and 6 months post-operatively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2018</start_date>
  <completion_date type="Anticipated">March 22, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 22, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Early Post-operative Intraocular Pressure</measure>
    <time_frame>2 hours after surgery</time_frame>
    <description>Intraocular Pressure measured by non-contact tonometers</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Corrected Visual Acuity (UCVA) at Distance</measure>
    <time_frame>baseline, 1 day, 1 week, 1 month, 3 months and 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uncorrected Visual Acuity (UCVA) at Distance</measure>
    <time_frame>baseline, 1 day, 1 week, 1 month, 3 months and 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial Cell Density</measure>
    <time_frame>baseline, 1 month, 3 months and 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vault measured by anterior segment OCT</measure>
    <time_frame>2 hours, 1 day, 1 week, 1 month, 3 months and 6 months after surgery</time_frame>
    <description>Vault measured by anterior segment OCT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraocular Pressure</measure>
    <time_frame>baseline, 1 day, 1 week, 1 month, 3 months and 6 months after surgery</time_frame>
    <description>Intraocular Pressure measured by non-contact tonometers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Refractive error (by Phoropter)</measure>
    <time_frame>baseline, 1 day, 1 week, 1 month, 3 months and 6 months after surgery</time_frame>
    <description>subjective refraction by Phoropter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anterior chamber reaction (by a laser flare meter)</measure>
    <time_frame>baseline, 2 hours, 1 day, 1 week after surgery</time_frame>
    <description>anterior chamber flare value was examined by a laser flare meter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of operation</measure>
    <time_frame>at the time of the surgery</time_frame>
    <description>Time from the first incision is made to the end of the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications of ICL implantation</measure>
    <time_frame>up to 6 months after surgery</time_frame>
    <description>Lens opacities, Cataract surgery, Pupillary block, Ocular hypertension or glaucoma</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>viscoelastic-free system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this group will use viscoelastic-free implantation system during the surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>viscoelastic-assisted system</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in this group will utilize the standard viscoelastic-assisted Implantation system during the surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>viscoelastic-free implantation system</intervention_name>
    <description>Viscoelastic-free implantation system use balanced salt solution irrigation during the implantation</description>
    <arm_group_label>viscoelastic-free system</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>standard viscoelastic-assisted Implantation system</intervention_name>
    <description>This method utilize the viscoelastic agent to fill and maintain the anterior chamber during the implantation</description>
    <arm_group_label>viscoelastic-assisted system</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Documented stable refraction for at least 1 year(within 0.5D)

          -  Best spectacle-corrected visual acuity (BCVA) of 20/40 or better

          -  Clear central cornea

          -  -0.5D to -18.0D of myopic refractive error

          -  Normal anterior chamber depth at least 2.8 mm to endothelium

          -  Endothelial cell density (ECD) more than 2000 cell/mm2

          -  Pupil diameter smaller than 7.0 mm under mesopic condition

          -  Discontinued 3 weeks for hard contact lens and 1 week for soft contact lens wear

        Exclusion Criteria:

          -  Preexisting ocular diseases or conditions other than myopia, evidence of progressive
             or acute ocular disease

          -  Evidence of connective tissue disease or other systemic diseases that may confound the
             results of the study;

          -  Narrow angle of anterior chamber

          -  Pregnant, lactating, or planning to become pregnant during the course of the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AYong Yu, MD. PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>AYong Yu, MD. PhD.</last_name>
    <phone>+86-0577-88068880</phone>
    <email>yaybetter@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anpeng Pan, MD.OD.</last_name>
    <email>pananpeng@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guangdong General Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jin Zeng, MD.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hunan Provincial People's Hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hua Wang, MD.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Eye Hispital of Wenzhou Medical University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anpeng Pan, MD.OD.</last_name>
      <phone>+86-577-88068809</phone>
      <email>pananpeng@126.com</email>
    </contact>
    <investigator>
      <last_name>Shuangqian Zhu, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kaijing Zhou, MD.PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Peking</city>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yan Luo, MD.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Ninth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jibo Zhou, MD.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2017</study_first_submitted>
  <study_first_submitted_qc>February 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wenzhou Medical University</investigator_affiliation>
    <investigator_full_name>A-Yong Yu</investigator_full_name>
    <investigator_title>Director of the Cataract Clinical Center</investigator_title>
  </responsible_party>
  <keyword>Phakic Intraocular Lenses</keyword>
  <keyword>viscoelastic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

